Van beleggers
voor beleggers
desktop iconMarkt Monitor

Ontvang nu dagelijks onze kooptips!

word abonnee

Aandeel UCB BRU:UCB.BL, BE0003739530

  • 85,660 9 jun 2023 17:36
  • 0,000 (0,00%) Dagrange 85,200 - 86,260
  • 172.965 Gem. (3M) 259,1K

Beurskoers UCB

1.861 Posts
Pagina: «« 1 ... 27 28 29 30 31 ... 94 »» | Laatste | Omlaag ↓
  1. Rhuno 22 oktober 2020 17:09
    UCB’s anti-epileptic drug VIMPAT® (lacosamide) receives EU CHMP positive opinion for primary generalised tonic-clonic seizures
    Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion on a licence extension for its anti-epileptic drugs VIMPAT (lacosamide) and Lacosamide UCB (lacosamide) as adjunctive therapy in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy1 (IGE)
    IGEs (idiopathic generalised epilepsy) account for 20%–40% of all epilepsies2, characterized by different generalized seizure types (absence, myoclonic and PGTCS)3
    Patients living with generalized tonic-clonic seizures have an increased risk of injury4 and those who experienced three or more in one year had a fifteen-fold increased risk of sudden unexpected death in epilepsy5
    UCB awaits decision from the European Commission (EC) on the potential approval of this new VIMPAT® license extension in the European Union
1.861 Posts
Pagina: «« 1 ... 27 28 29 30 31 ... 94 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord

Direct naar Forum

UCB Meer »

Koers 85,660   Verschil 0,00 (0,00%)
Laag 85,200   Volume 172.965
Hoog 86,260   Gem. Volume 259.125
9 jun 2023 17:36
Premium

UCB neemt Ra Pharmaceuticals over

Het laatste advies leest u als abonnee van IEX Premium

Inloggen Ontdek IEX Premium

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links